ROR alpha protects against LPS-induced inflammation by down-regulating SIRT1/NF-kappa B pathway
Copyright © 2019 Elsevier Inc. All rights reserved..
Systemic inflammatory response syndrome (SIRS) is associated with excessive inflammatory response, however, the pathophysiology of inflammation is poorly understood. The retinoid-related orphan receptor α (RORα) is a key inflammatory regulator, but the mechanisms underlying its role remain unclear. The aim of this study was to investigate how RORα was involved in the regulation of inflammatory response. Here we put forward a hypothesis that RORα might negatively regulate inflammatory response by controlling silent information regulator Sirtuin 1 (SIRT1) expression. Stimulation of macrophages in vitro with LPS and LPS administration in vivo were used to explore the function of RORα and the relationship between RORα and SIRT1. We found that the level of RORα was suppressed in macrophages stimulated with LPS and overexpression or knockdown of RORα by transfection with lentivirus or siRNAs significantly decreased or increased, respectively, the pro-inflammatory cytokines IL-1β, TNF, IL-6 and MCP-1. Importantly, overexpression of RORα suppressed inflammation and alleviated LPS-induced organ injury in vivo. Further study showed that RORα could regulate SIRT1 expression and, consequently, affect deacetyation and nuclear translocation of nuclear factor-kappa B (NF-κB) subunit p65. Moreover, the activation of SIRT1 by its specific agonist, SR1720, could reduce the expression of proinflammatory cytokines in RORα knockdown macrophages stimulated with LPS. In conclusion, we demonstrated that RORα could alleviate LPS-induced inflammation and organ injury both in vivo and in vitro by blocking NF-κB p65 nuclear translocation and restricting acetylation of NF-κB p65 at lysine 310 via the regulation of SIRT1 expression. Targeting RORα might be a promising therapeutic strategy to regulate inflammatory disorders.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:668 |
---|---|
Enthalten in: |
Archives of biochemistry and biophysics - 668(2019) vom: 15. Juni, Seite 1-8 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Han, Shichao [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 27.02.2020 Date Revised 27.02.2020 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.abb.2019.05.003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM296905542 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM296905542 | ||
003 | DE-627 | ||
005 | 20231225090837.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.abb.2019.05.003 |2 doi | |
028 | 5 | 2 | |a pubmed24n0989.xml |
035 | |a (DE-627)NLM296905542 | ||
035 | |a (NLM)31071300 | ||
035 | |a (PII)S0003-9861(19)30130-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Han, Shichao |e verfasserin |4 aut | |
245 | 1 | 0 | |a ROR alpha protects against LPS-induced inflammation by down-regulating SIRT1/NF-kappa B pathway |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.02.2020 | ||
500 | |a Date Revised 27.02.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2019 Elsevier Inc. All rights reserved. | ||
520 | |a Systemic inflammatory response syndrome (SIRS) is associated with excessive inflammatory response, however, the pathophysiology of inflammation is poorly understood. The retinoid-related orphan receptor α (RORα) is a key inflammatory regulator, but the mechanisms underlying its role remain unclear. The aim of this study was to investigate how RORα was involved in the regulation of inflammatory response. Here we put forward a hypothesis that RORα might negatively regulate inflammatory response by controlling silent information regulator Sirtuin 1 (SIRT1) expression. Stimulation of macrophages in vitro with LPS and LPS administration in vivo were used to explore the function of RORα and the relationship between RORα and SIRT1. We found that the level of RORα was suppressed in macrophages stimulated with LPS and overexpression or knockdown of RORα by transfection with lentivirus or siRNAs significantly decreased or increased, respectively, the pro-inflammatory cytokines IL-1β, TNF, IL-6 and MCP-1. Importantly, overexpression of RORα suppressed inflammation and alleviated LPS-induced organ injury in vivo. Further study showed that RORα could regulate SIRT1 expression and, consequently, affect deacetyation and nuclear translocation of nuclear factor-kappa B (NF-κB) subunit p65. Moreover, the activation of SIRT1 by its specific agonist, SR1720, could reduce the expression of proinflammatory cytokines in RORα knockdown macrophages stimulated with LPS. In conclusion, we demonstrated that RORα could alleviate LPS-induced inflammation and organ injury both in vivo and in vitro by blocking NF-κB p65 nuclear translocation and restricting acetylation of NF-κB p65 at lysine 310 via the regulation of SIRT1 expression. Targeting RORα might be a promising therapeutic strategy to regulate inflammatory disorders | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Inflammation | |
650 | 4 | |a Lipopolysaccharide | |
650 | 4 | |a Macrophage | |
650 | 4 | |a NF-κB | |
650 | 4 | |a RORα | |
650 | 4 | |a SIRT1 | |
650 | 7 | |a Cytokines |2 NLM | |
650 | 7 | |a Lipopolysaccharides |2 NLM | |
650 | 7 | |a NF-kappa B p50 Subunit |2 NLM | |
650 | 7 | |a Nuclear Receptor Subfamily 1, Group F, Member 1 |2 NLM | |
650 | 7 | |a Rora protein, mouse |2 NLM | |
650 | 7 | |a Transcription Factor RelA |2 NLM | |
650 | 7 | |a Nfkb1 protein, mouse |2 NLM | |
650 | 7 | |a 147257-52-1 |2 NLM | |
650 | 7 | |a Sirt1 protein, mouse |2 NLM | |
650 | 7 | |a EC 3.5.1.- |2 NLM | |
650 | 7 | |a Sirtuin 1 |2 NLM | |
650 | 7 | |a EC 3.5.1.- |2 NLM | |
700 | 1 | |a Li, Zhenzhen |e verfasserin |4 aut | |
700 | 1 | |a Han, Fu |e verfasserin |4 aut | |
700 | 1 | |a Jia, Yanhui |e verfasserin |4 aut | |
700 | 1 | |a Qi, Lijun |e verfasserin |4 aut | |
700 | 1 | |a Wu, Gaofeng |e verfasserin |4 aut | |
700 | 1 | |a Cai, Weixia |e verfasserin |4 aut | |
700 | 1 | |a Xu, Yongqiang |e verfasserin |4 aut | |
700 | 1 | |a Li, Cong |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Wanfu |e verfasserin |4 aut | |
700 | 1 | |a Hu, Dahai |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Archives of biochemistry and biophysics |d 1951 |g 668(2019) vom: 15. Juni, Seite 1-8 |w (DE-627)NLM000012998 |x 1096-0384 |7 nnns |
773 | 1 | 8 | |g volume:668 |g year:2019 |g day:15 |g month:06 |g pages:1-8 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.abb.2019.05.003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 668 |j 2019 |b 15 |c 06 |h 1-8 |